Dexcom (DXCM) financial statements

+15600.7%since 2009
FY2025 revenue
$4.7B▲ +15.6%
FY2025 net income
$836M▲ +45.1%
FY2025 diluted EPS
$2.09▲ +47.2%
FY2025 free cash flow
$1.1B▲ +70.8%

Dexcom income statement

Dexcom income statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Revenue4,6624,0333,622
Gross profit2,8022,4382,289
Operating income912600598
Pretax income1,088709710
Net income836576542
Diluted earnings per share2.091.421.30

Dexcom balance sheet

Dexcom balance sheet
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Cash and cash equivalents918607566
Total assets6,3406,4856,265
Total liabilities3,5944,3824,196
Total equity2,7462,1032,069

Dexcom cash flow statement

Dexcom cash flow statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Operating cash flow1,441990749
Capital expenditure-363-359-237
Free cash flow (derived)1,077631512
Share repurchases-500-750-689

Quarterly highlights

Quarterly highlights
USD millionsQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Period ended30 Sep 202630 Jun 202631 Mar 202631 Dec 2025
Revenue (derived)1,3451,3081,1921,260
Operating income (derived)327318255323
Net income (derived)275249200267
Diluted earnings per share0.720.640.51n/a
Operating cash flow (derived)326269526294
Total assets6,2396,4556,6336,340

Dexcom major shareholders

Dexcom major shareholders
HolderShare of classSharesFiled
BlackRock, Inc.8.3%32,504,14024 April 2025
Vanguard Capital Management7.5%28,848,21830 April 2026
Vanguard Portfolio Management5.0%19,322,56629 April 2026

Dexcom 10-K and SEC filings

Dexcom 10-K and SEC filings
FiledFormTypeDescription
29 October 202610-QQuarterly reportQuarterly report
29 October 20268-KCurrent reportCurrent report
14 September 20268-KCurrent reportCurrent report
10 September 20268-KCurrent reportCurrent report
30 July 202610-QQuarterly reportQuarterly report
30 July 20268-KCurrent reportCurrent report
28 May 20268-KCurrent reportCurrent report
14 May 20268-KCurrent reportCurrent report

Common questions

What was Dexcom's revenue in fiscal 2025?

Dexcom reported $4.7 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 15.6% from fiscal 2024.

What was Dexcom's net income in fiscal 2025?

Dexcom reported net income of $836 million for fiscal 2025, the year ended 31 December 2025, up 45.1% from fiscal 2024. Diluted earnings per share were $2.09.

What was Dexcom's free cash flow in fiscal 2025?

Dexcom had $1.1 billion in free cash flow in fiscal 2025. Operating cash flow was $1.4 billion and capital expenditure was $364 million.

What were Dexcom's total assets at the end of fiscal 2025?

Dexcom reported total assets of $6.3 billion at the end of fiscal 2025, the year ended 31 December 2025.

How much Dexcom history does each plan include?

Free covers the last 3 fiscal years of annual figures. Basic covers the last 10 fiscal years, annual and quarterly. Pro covers the full history, with first reported values and as of dates.